News & Press

Here you will find an indexed repository of all news releases pertaining to Belgravia Capital.

BELGRAVIA corporate update

OPEN PDF

BELGRAVIA DERMATOLOGY COMPLETES IDENTIFICATION OF INITIAL DRUG TARGETS WITHIN THE SKIN ENDOCANNABINOID SYSTEM AND ALSO IDENTIFIES BIO MARKERS FOR PRE CLINICAL WORK IN ACNE

OPEN PDF

BELGRAVIA CAPITAL completes acquisition of interest in R&D Pharma Corp., a Canadian corporation building a vertically integrated medical cannabis business in Jamaica

OPEN PDF

BELGRAVIA COMPLETES TRANSITION OF ICP ORGANICS TO DERMATOLOGY PRODUCT DEVELOPMENT, RENAMES ICP ORGANICS TO BELGRAVIA DERMATOLOGY INC., AND APPOINTS SIDNEY HIMMEL DIRECTOR OF BELGRAVIA DERMATOLOGY

OPEN PDF

BELGRAVIA announces results of Annual Meeting

OPEN PDF

BELGRAVIA APPOINTS DR. SAM HANNA CHIEF MEDICAL OFFICER OF CANNABIS DERMATOLOGY DIVISION

OPEN PDF

BELGRAVIA CAPITAL adds to expertise in corporate development and expands medical advisory committee

OPEN PDF

BELGRAVIA CAPITAL signs Binding Letter of Intent with R&D Pharma Corp., a developer of a vertically integrated medicinal cannabis business in Jamaica, to invest Canadian $1,000,000.

OPEN PDF

BELGRAVIA CAPITAL INTERNATIONAL and Fanlogic Commence Design of Blockchain Loyalty Program for the Global Cannabis Industry

OPEN PDF

BELGRAVIA CAPITAL INTERNATIONAL announces closing of private placement

OPEN PDF
Scroll to top